This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

GEM - thalassaemia answer part 2

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

  • the Thalassemias are Autosomal Recessive conditions. In these conditions if the child inherited one copy of the gene, e.g. one copy of the gene variant that leads to less production of beta globin protein, the child will be a healthy carriers. However if the child inherits 2 copies of the gene varient (one copy from each parent) they can have the disease, in this example Beta Thalaessemia.
  • when only one partner carries a gene variant, he or she can pass on to a child either the usual gene or the gene variant. Each child therefore has a 1 in 2 (50%) chance of inheriting the variant and being a healthy carrier. None of the children can have a serious haemoglobin disorder. Each child also has a 50% chance of carrying the usual gene. Healthy carriers can pass on haemoglobin gene variants for many generations, without anyone realising that a variant is "in the family".
  • when both partners carry a gene variant, each can pass on to a child either the usual gene or the gene variant. There are four possible combinations of genes: At each conception there is a 25% (1 in 4) probability of a child with usual haemoglobin, a 50% (1 in 2) probability of a healthy carrier, and a 25% (1 in 4) probability of a inheriting 2 copies of the gene varient and child with a thalasseamia

Create an account to add page annotations

Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.